Peptide Compass · Research

Sermorelin: research, prices and suppliers

A short-chain fragment of the body's own GHRH, historically approved as a medication, now sold as a research substance.

Sources and dates are stated with individual entries. This new presentation is not a complete re-investigation of all data.

Sermorelin is the biologically active fragment GHRH(1-29) of the body's own growth hormone-releasing hormone. In the US it was approved in 1990 as a diagnostic agent and in 1997 for growth hormone deficiency-related short stature in children; the approval was withdrawn in 2008 for manufacturing reasons. Today it is studied outside that historical approval as a research substance.

Facts

  • CAS number: 86168-78-7
  • Molecular weight: 3357.9 g/mol
  • Amino acids: 29
  • Purity specification: ≥ 98 % (HPLC, commercial standard)
  • Solubility: soluble in water and dilute acetic acid

Evidence

  • In a randomized, placebo-controlled trial in older men and women, an Nle27-substituted GHRH(1-29) analog raised growth hormone and IGF-1 levels over several months and improved fat-free body mass. Khorram et al. 1997, Journal of Clinical Endocrinology & Metabolism, PMID 9141536
  • A review of the available clinical data in children with growth hormone deficiency described accelerated growth velocity over twelve months in most of the children studied. Prakash & Goa 1999, BioDrugs, PMID 18031173

Frequently asked questions

Was Sermorelin once an approved medication


Yes. Sermorelin was approved in the US from 1990 to 2008, first as a diagnostic agent, later for growth hormone deficiency-related short stature in children. The approval was withdrawn for manufacturing reasons, not safety concerns.

What is the difference between sermorelin and CJC-1295


Both are GHRH analogs. Sermorelin consists of the first 29 amino acids of the body's own GHRH with no further modification, while CJC-1295 is additionally stabilized and therefore has a longer half-life.

Is sermorelin available as a medication today


No. Since the market withdrawal in 2008, sermorelin is no longer available as an approved medication in the EU or the US and is sold as a research chemical.

Documented prices

Prices are recorded snapshots. Each entry states its date, currency and pack variant. Shipping, tax treatment, discount conditions and availability must be rechecked in the shop. A low price is not evidence of quality.

List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.

VendorPackList pricePrice/mgRecordedSource
Peptide Labz5 mg35 EUR7.0 EUR/mg2026-09-15Product page · Ad
Bio BoostX10 mg64.95 EUR6.5 EUR/mg2026-09-15Product page · Ad
Peptide Shop Deutschland10 mg69.99 EUR7.0 EUR/mg2026-09-15Product page · Ad
Peptide Labz10 mg75 EUR7.5 EUR/mg2026-09-15Product page · Ad
Chameleon Peptides5 mg36 USD7.2 USD/mg2026-09-15Product page · Ad
Protide Health5 mg55 USD11.0 USD/mg2026-09-15Product page · Ad
American Peptides5 mg60 USD12.0 USD/mg2026-09-15Product page · Ad
Licensed Peptides5 mg68.99 USD13.8 USD/mg2026-09-15Product page · Ad
Chameleon Peptides10 mg54 USD5.4 USD/mg2026-09-15Product page · Ad
Protide Health10 mg105 USD10.5 USD/mg2026-09-15Product page · Ad

Questions about interpretation

What does the search “Sermorelin protocol” mean?

“Protocol” is often used to mean a regimen. This page explains research and documented listings. It contains no doses, cycles or instructions for human use. An online regimen is not scientifically validated simply because it is widely shared.

Sources and data basis

These references come from the existing dataset. A link alone verifies neither a study claim nor supplier quality. Uncertainty remains explicit where records are undated or incomplete.

Where to go next

Created with AI assistance. This new edition has not yet received independent editorial review.